Theriva Biologics announces 2023 annual meeting voting results; directors elected, auditor ratified

Theriva Biologics, Inc.

Four directors elected: Kraws, Shallcross, Monahan, Wolf; votes for ranged from 1,996,551 to 2,553,173, with 4,077,933 broker non-votes each.
Ratification of BDO USA P.C. as independent auditor for FY 2023: 7,059,989 for, 171,037 against, 182,495 abstentions.
Meeting held October 2, 2023; no other proposals voted on.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Theriva Biologics, Inc. shareholders approved Ratification of the appointment of BDO USA P.C. as the Company’s independent registered public accounting firm for the year ending December 31, 2023 at the 2023-10-02 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-10-02

Exact text from the filing

Proposal 2 — Ratification of the appointment of BDO USA P.C. as the Company’s independent registered public accounting firm for the year ending December 31, 2023. The stockholders ratified and approved the appointment

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Theriva Biologics, Inc. shareholders approved Election of Directors at the 2023-10-02 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-10-02

Exact text from the filing

Proposal 1 — Election of Directors . The following four (4) individuals were elected as directors

View on SEC.gov

Browse all shareholder votes →

Theriva Biologics, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-106102

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.